Genscript

Company Overview

GenScript is a biotechnology company that uses proprietary gene synthesis technology and expertise in life science research to support the global scientific community. It operates through three segments: life science services and products, biologics development services, and industrial synthetic biology products. The life science services and products business segments offer gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, and antibody development, as well as provide life-science equipment and consumables, including molecular diagnostics tools, genome editing materials, and chromatography resins. Its products and services are widely utilized across various life-science research and application areas. The services and products of GenScript are essential to a broad range of life-science research and applications, including basic biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine development, agriculture, environmental studies, and the food industry.

The biologic development services segment provides viral vectors, DNA, RNA, antibodies, and proteins for biologics development and manufacturing for biopharma companies. The industrial synthetic biology products segment provides synthetically developed microbial strains for producing high-quality industrial enzymes and functional proteins, which are utilized in various industries, including food, feed, pharmaceutical, and chemical sectors. It serves over 100 countries and regions with legal entities in locations such as the U.S., Mainland China, Japan, and others.

Financial Highlights (FY 2025)

Company's Business Segments

• Life-science Services and Products : This  segment provides a broad range of offerings, such as customised DNA synthesis, oligo nucleotide synthesis, protein production, peptide synthesis, catalog equipment, antibody development, and consumables.
• Biologics Development Services : This segment offers an integrated end-to-end service offerings to enhance biologics development and manufacturing for biotech and biopharma partners.
• Industrial Synthetic Biology Products : This segment helps in developing industrial enzyme through non-pathogenic microbial strains built using genetic engineering.
• Cell Therapy : This segment discovers and develops advanced CAR-T therapies for the treatment of liquid and solid tumors.